Therapeutic Asset Ratings
165 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
il-15
Cancer
Essen Biotech
P1/2
CC
(41)
il-15
Esophageal Cancer
Essen Biotech
P1/2
CC
(41)
il-15
Glioblastoma
Essen Biotech
P1/2
CC
(41)
Bcma/Gprc5D Car-T Cells
Plasma Cell Myeloma
Essen Biotech
P1/2
CC
(40)
Claudin18.2 Car-T Cells
Pancreatic Neoplasm
Essen Biotech
P1/2
CC
(40)
Dual-Target Antigen-Selected Car-Nk
Breast Cancer
Essen Biotech
P1/2
CC
(40)
Dual-Target Antigen-Selected Car-Nk
Ovarian Cancer
Essen Biotech
P1/2
CC
(40)
EBNK-001
Colorectal Cancer
Essen Biotech
P1/2
CC
(40)
EBNK-001
Ovarian Cancer
Essen Biotech
P1/2
CC
(40)
Eb-Select Single-Target Car-Nk Cells
Breast Cancer
Essen Biotech
P1/2
CC
(40)
Eb-Select Single-Target Car-Nk Cells
Ovarian Cancer
Essen Biotech
P1/2
CC
(40)
gpc3 cd146 car-t cells
Ovarian Cancer
Essen Biotech
P1/2
CC
(40)
il-15
Colorectal Cancer
Essen Biotech
P1/2
CC
(40)
il-15
Ovarian Cancer
Essen Biotech
P1/2
CC
(40)
Mesothelin-Directed Car-T Cells
Pancreatic Cancer
Essen Biotech
P1/2
CC
(40)
Showing 151 to 165 of 165 assets
Previous
Page 7 of 7
Next
